BERKSHIRE MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $588K
- Transactions
- 194
- Companies
- 26
- Average per transaction
- $3,030
Who reported the payments
| Takeda Pharmaceuticals U.S.A., Inc. | $328,811 |
| Indivior Inc. | $95,971 |
| Instrumentation Laboratory Company | $61,020 |
| Pharmacyclics LLC, An Abbvie Company | $16,062 |
| Incyte Corporation | $16,023 |
| GSK | $12,102 |
| Pfizer | $10,950 |
| Johnson & Johnson | $8,423 |
| Genmark Diagnostics, Inc. | $6,312 |
| KARL Storz Endoscopy-america | $6,032 |
| Medline Industries LP | $5,020 |
| Masimo Corporation | $4,876 |
| Genentech, Inc. | $4,010 |
| Sysmex America, Inc. | $1,786 |
| Seagen Inc. | $1,700 |
| Morphosys AG | $1,604 |
| Sterilmed, Inc. | $1,298 |
| Biofire Diagnostics, LLC | $1,239 |
| Verastem, Inc. | $1,116 |
| GE HealthCare | $1,110 |
| Organon | $700 |
| Integra Lifesciences Corporation | $500 |
| New York Blood Center, Inc. | $436 |
| Stryker | $299 |
| Linvatec Corporation | $269 |
| Immucor, Inc. | $129 |